Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-08 4:03 pm Purchase | 13D | HUMACYTE INC HUMA | Niklason Laura E | 10,153,195 8.4% | 102,373 (+1.02%) | View |
| 2023-09-15 4:09 pm Sale | 13D | HUMACYTE INC HUMA | Niklason Laura E | 10,050,822 9.5% | -1,561,987 (-13.45%) | View |
| 2023-08-21 6:19 pm Sale | 13D | HUMACYTE INC HUMA | Niklason Laura E | 11,612,809 11.1% | -2,298,579 (-16.52%) | View |
| 2023-06-15 4:23 pm Sale | 13D | HUMACYTE INC HUMA | Niklason Laura E | 13,911,388 13.2% | -4,874,823 (-25.95%) | View |
| 2023-05-26 5:05 pm Sale | 13D | HUMACYTE INC HUMA | Niklason Laura E | 18,786,211 17.9% | -3,550,200 (-15.89%) | View |
| 2022-09-19 4:39 pm Sale | 13D | HUMACYTE INC HUMA | Niklason Laura E | 22,336,411 21.3% | -931,868 (-4.00%) | View |
| 2021-08-27 9:14 pm Purchase | 13D | HUMACYTE INC HUMA | Niklason Laura E | 23,268,279 22.4% | 23,268,279 (New Position) | View |